Youth Risk Behavior Surveillance System |
YRBSS |
Clinical Trial: Indicated Prevention with At-Risk Gamblers
This study is currently recruiting patients.
|
Purpose
The overall purpose of this study is to reduce the prevalence of gambling risk in college students by evaluating the effectiveness of different treatments in reducing gambling behavior and related negative consequences.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Gambling | Behavior: Brief Personal Feedback Intervention Behavior: Cognitive Behavioral Therapy | Phase II |
MedlinePlus related topics: Mental Health
Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Expected Total Enrollment: 225
Study start: July 2003; Expected completion: June 2006
Participants in this study will be randomly assigned to a personal feedback intervention (PFI), cognitive behavioral therapy (CBT), or assessment only for 3 years. The PFI intervention will be delivered in a single session; CBT will be delivered in six weekly sessions. Measures will include the NORC DSM Screen for Problem Gambling (NODS), the South Oaks Gambling Screen (SOGS), Gambling Quantity and Perceived Norms, Perceived Injunctive Gambling Norms, Gambling Problems Index, gambling frequency, attitudes and beliefs about gambling and self-control, readiness to change, gambling expectancies, gambling motives, gambling risk perception, psychiatric symptoms, assertiveness, coping skills, substance use, alcohol-related problems, self-determination, and social desirability.
Eligibility
Ages Eligible for Study: 17 Years - 24 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- College student
- South Oaks Gambling Screen (SOGS) score between 3 and 4 or SOGS score of 5
Location and Contact Information
Washington
University of Washington; Department of Psychiatry and Behavioral Sciences, Seattle, Washington, 98195, United States; Recruiting
Mary E. Larimer, PhD, Principal Investigator
Clayton Neighbors, PhD, Sub-Investigator
More Information
Record last reviewed: August 2004
Last Updated: October 13, 2004
Record first received: February 20, 2004
ClinicalTrials.gov Identifier: NCT00078273
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


